Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-018931

Chief Operating Officer bought 36,000 shares at an average $0.64 ($23,051)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2024-05-29 Purchase +12,000 $0.64 $7,643 69,624 D
Cittadine Andrew Chief Operating Officer 2024-05-30 Purchase +12,000 $0.64 $7,676 81,624 D
Cittadine Andrew Chief Operating Officer 2024-05-31 Purchase +12,000 $0.64 $7,732 93,624 D
Open-market purchases · 36,000 sh · avg $0.64 · $23,051
Loading xslF345X05/rdgdoc.xml…